Ligand validation:6JLN

SQD: 1,2-DI-O-ACYL-3-O-[6-DEOXY-6-SULFO-ALPHA-D-GLUCOPYRANOSYL]-SN-GLYCEROL

SQD is a Ligand Of Interest in 6JLN designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6JLN_SQD_A_411	19%	38%	0.227	0.823	0.98	1.53	3	11	0	0	100%	1
6JLN_SQD_a_414	18%	37%	0.253	0.842	0.95	1.57	3	11	0	0	100%	1
6JLN_SQD_A_413	8%	45%	0.272	0.736	1.02	1.15	3	6	0	0	100%	1
6JLN_SQD_a_405	7%	43%	0.305	0.764	1.08	1.19	3	4	0	0	100%	1
6JLN_SQD_F_101	5%	31%	0.367	0.815	1.17	1.69	3	11	0	0	80%	0.7963
6JLN_SQD_L_102	4%	35%	0.335	0.703	1.05	1.59	3	12	0	0	100%	1
6JLN_SQD_B_621	2%	39%	0.464	0.732	1.01	1.41	3	5	0	0	100%	1
6JLN_SQD_f_102	2%	35%	0.313	0.601	1.19	1.45	3	7	0	0	80%	0.7963
5V2C_SQD_a_413	94%	24%	0.075	0.976	1.12	2.14	4	12	0	0	100%	1
6DHE_SQD_A_412	77%	23%	0.113	0.961	1.05	2.27	5	14	0	0	96%	0.963
8IRC_SQD_a_411	77%	32%	0.119	0.96	0.96	1.83	3	13	0	0	100%	1
8IR5_SQD_a_411	75%	33%	0.123	0.958	0.95	1.77	3	13	0	0	100%	1
8IRF_SQD_a_410	75%	32%	0.125	0.96	0.96	1.83	3	13	0	0	100%	0.49
8IR8_SQD_a_409	75%	33%	0.126	0.96	0.95	1.77	3	13	0	0	100%	0.4

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.